Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 83858 refers to a laboratory test specifically designed to measure the levels of methsuximide in the blood. Methsuximide, which is marketed under the brand name Celontin, is classified as a succinimide anticonvulsant medication. It is primarily utilized in the management of absence seizure disorders, which are characterized by brief episodes of impaired consciousness. The measurement of methsuximide levels is crucial for monitoring therapeutic drug levels in patients undergoing treatment, ensuring that the medication is effective while minimizing the risk of toxicity. The test involves obtaining a blood sample through a procedure known as venipuncture, which is a separate reportable service. The analysis of the serum or plasma is conducted using quantitative gas chromatography, a precise method that allows for the accurate quantification of the drug concentration in the blood. This testing is essential for healthcare providers to make informed decisions regarding dosage adjustments and overall treatment efficacy for patients with seizure disorders.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure associated with CPT® Code 83858 is indicated for the following conditions:
The procedure for obtaining a methsuximide level involves several key steps that ensure accurate testing and patient safety:
After the procedure, the patient may experience minor discomfort at the venipuncture site, which typically resolves quickly. It is important for healthcare providers to monitor the patient for any immediate adverse reactions. The results of the methsuximide level test will be analyzed and reported back to the prescribing physician, who will use this information to make informed decisions regarding the patient's ongoing treatment plan. Patients may be advised to follow up with their healthcare provider to discuss the results and any necessary adjustments to their medication regimen.
| Short Descr | ASSAY OF METHSUXIMIDE | Medium Descr | METHSUXIMIDE | Long Descr | Methsuximide | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 9 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Items and Services Packaged into APC Rates | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | Not applicable/unspecified. | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
Get instant expert-level medical coding assistance.